Skip to main content
. 2022 Aug 1;13(1):1216–1220. doi: 10.1080/21505594.2022.2098922

Figure 1.

Figure 1.

a) Feline and canine serum samples were collected during the spring (from mid-April to mid-June 2020) and winter months (from mid-November 2020 to mid-January 2021) in Minnesota, USA, and were used to screen for serological evidence of SARS-CoV-2 exposure by the SARS-CoV-2 N-based enzyme-linked immunosorbent assay (ELISA). b) Graph comparing the levels of SARS-CoV-2 seropositivity in feline (blue bars) and canine (orange bars) serum samples in the spring and winter months when there is a surge in the number of new daily cases of COVID-19 in humans in Minnesota (grey shaded areas). Data for human daily COVID-19 cases was reported [10]. Percent seroprevalence of SARS-CoV-2 in feline and canine species are shown on the left Y-axis and the human daily COVID-19 case number are shown on the right Y-axis over time(x-axis).